The Home Depot, Inc.
—- Market cap
- —
- Debt
- +$51.31B
- Cash
- −$1.39B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: HD stock price vs AZTA: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AZTA's multiple
Needs AZTA P/E.
Implied fair value · at HD's multiple
Needs Annual EPS is negative, HD P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
The Home Depot, Inc. · implied price per share
Bear
$86.60
Base
$109.07
Bull
$140.31
AZENTA, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LOWES COMPANIES INC
HD vs LOW
FASTENAL CO
HD vs FAST
W.W. GRAINGER, INC.
HD vs GWW
STANLEY BLACK & DECKER, INC.
HD vs SWK
WHIRLPOOL CORP /DE/
HD vs WHR
TRACTOR SUPPLY CO /DE/
HD vs TSCO
THERMO FISHER SCIENTIFIC INC.
HD vs TMO
ILLUMINA, INC.
HD vs ILMN
AGILENT TECHNOLOGIES, INC.
HD vs A
BIO-TECHNE Corp
HD vs TECH
BRUKER CORP
HD vs BRKR
WATERS CORP /DE/
HD vs WAT
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe HD can sustain its 3.2% revenue growth and 33.3% ROIC while the market continues to value it near AZTA-implied P/S framework, then a selective accumulation makes sense because the current price still sits 12.8% below that reference point.
HD's current price of $340.02 sits 12.8% below AZTA-implied price of $383.48 based on the P/S comparison, suggesting some relative undervaluation on that single basis. However, the stock is already near the upper end of its historical band and materially above the DCF range, so the valuation picture is not uniformly cheap.
Supporting Metrics